Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
91
Frequently Asked Questions
What is Market Cap of Cumberland Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cumberland Pharmaceuticals Inc. market cap is $47.27M.
What is the 52-week high for Cumberland Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cumberland Pharmaceuticals Inc. 52 week high is $7.25 as of September 30, 2025.
What is the 52-week low for Cumberland Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cumberland Pharmaceuticals Inc. 52 week low is $1.04 as of September 30, 2025.
What is Cumberland Pharmaceuticals Inc. stock price today?
Cumberland Pharmaceuticals Inc. stock price today is $3.12.
What was Cumberland Pharmaceuticals Inc. stock price yesterday?
Cumberland Pharmaceuticals Inc. stock price yesterday was $3.16.
What is the PE ratio of Cumberland Pharmaceuticals Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cumberland Pharmaceuticals Inc.’s P/E ratio is -14.81.
What is the Price-to-Book ratio of Cumberland Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cumberland Pharmaceuticals Inc. P/B ratio is 1.6890.
What is the 50-day moving average of Cumberland Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cumberland Pharmaceuticals Inc. 50-day moving average is $3.32.
How many employess does Cumberland Pharmaceuticals Inc. has?
